(Q51861450)

14 April 2018

editorial

0 references

title

Therapy of H7N9 pneumonia: current perspectives. (English)

1 reference

14 April 2018

0 references

2

Frederick G Hayden

1 reference

14 April 2018

author name string

Bin Cao

series ordinal

1

1 reference

14 April 2018

publication date

1 November 2013

1 reference

14 April 2018

Expert Review of Anti-infective Therapy

published in

1 reference

14 April 2018

volume

11

1 reference

14 April 2018

issue

11

1 reference

14 April 2018

page(s)

1123-1126

1 reference

14 April 2018

Human infection with a novel avian-origin influenza A (H7N9) virus

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.847787

Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.847787

Clinical findings in 111 cases of influenza A (H7N9) virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.847787

Biological features of novel avian influenza A (H7N9) virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.847787

Antiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.847787

Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.847787

Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.847787

Newer influenza antivirals, biotherapeutics and combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.847787

Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.847787

Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.847787

Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.847787

Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.847787

Prone positioning in severe acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.847787

Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.847787

Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.847787

What is the role of steroids in pneumonia therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.847787

10.1586/14787210.2013.847787

21 January 2018

Identifiers

DOI

1 reference

14 April 2018

1 reference

14 April 2018